DHR vs WFC: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Wells Fargo & Company · Financial Services
$82.21
+30.2% upside to fair value
Grade B
QuantHub Verdict
WFC has more upside to fair value
(+30.2%).
WFC trades at a lower forward P/E
(12.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
WFC |
| Current Price |
$177.17 |
$82.21 |
| Fair Value Estimate |
$192.90 |
$107.03 |
| Upside to Fair Value |
+8.9%
|
+30.2%
|
| Market Cap |
$125.4B |
$251.6B |
| Forward P/E |
34.1x
|
12.0x
|
| EV / EBITDA |
20.8x
|
15.8x
|
| Price / Sales |
5.1x
|
2.0x
|
| Price / FCF |
23.7x
|
213.4x
|
| Revenue Growth YoY |
+3.7%
|
+7.3%
|
| Gross Margin |
60.7%
|
64.5%
|
| Operating Margin |
21.0%
|
20.5%
|
| Return on Equity |
7.1%
|
12.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
0.47%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Wells Fargo & Company is a diversified financial services firm with a strong presence in consumer banking, commercial banking, corporate and investment banking, and wealth management. The company benefits from a large-scale moat in deposits, payments, and distribution, supported by a seasoned management team led by CEO Charles W. Scharf. Despite regulatory challenges and customer service issues t…
Accumulation Zones
| Metric |
DHR |
WFC |
| Zone Low |
$144.68 |
$80.27 |
| Zone High |
$163.97 |
$90.98 |
| In Buy Zone? |
No
|
Yes
|